Brightgene is an operator-led fund. Known portfolio companies include Citryll, DNALite Therapeutics and Aoli Biotechnology, 3 companies in all.
Is Brightgene a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Brightgene portfolio companies (3)
- Citryll
- DNALite Therapeutics
- Aoli Biotechnology
Co-investors
Funds that share portfolio companies with Brightgene.
Similar funds
Showing 20 of 100
About Brightgene
The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery and Pharma; known deals cluster at Seed, Series A and Series B.
Across the known portfolio, 6 co-investors appear alongside Brightgene, including Bgv (biogeneration Ventures), Blue Bear Capital and Highlight Capital.
Frequently asked questions
What is Brightgene?
Brightgene is an operator-led fund with a known portfolio of 3 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Brightgene invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Brightgene invest at?
The known deals of Brightgene include Seed, Series A and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact Brightgene?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal